Research ArticleOriginal Articles
Open Access

Awareness of Saudi community toward multiple sclerosis in Qassim Region, Saudi Arabia

Nourah A. Al-Hamdan, Eman A. Al-Otaibi, Manal A. Al-Mutairi, Malak G. Al-Mutairi, Ola A. Al-Otaibi, Marwah A. Al-Mozeri, Weam K. Al-Masaud and Manal A. Al-Batanony
Neurosciences Journal January 2021, 26 (1) 77-84; DOI: https://doi.org/10.17712/nsj.2021.1.20200115

References

  1. ↵
    1. Calabresi PA
    (2004) Diagnosis and management of multiple sclerosis american family physician. Am Fam Physician 70:1935–1944.
    OpenUrlPubMedWeb of Science
  2. ↵
    1. Shanahan JK,
    2. Davis JKJ
    1. Kasper D,
    2. Fauci A,
    3. Hauser S,
    4. Longo D,
    5. Jameson JL,
    6. Loscalzo J
    (2015) Harrison's Principles of Internal Medicine, 19th edition, eds Shanahan JK, Davis JKJ (McGraw-Hill), 2015, p 1013.
  3. ↵
    1. Koch-Henriksen N,
    2. Sørensen PS
    (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520–532.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Kurtzke JF
    (2000) Epidemiology of multiple sclerosis. Does this really point toward an etiology?Lectio Doctoralis. Neurol Sci 21:383–403.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Wallin MT
    (2019) Global, regional, and national burden of multiple sclerosis 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:269–285.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Multiple Sclerosis International Federation
    What is MS:MS International Federation, Available from URL: https://www.msif.org/about-ms/what-is-ms/. Updated 2020 September 14. Cited 2020 June 30.
  7. ↵
    1. Trapp BD,
    2. Nave KA
    (2008) Multiple sclerosis:an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Korn T
    (2008) Pathophysiology of multiple sclerosis. J Neurol 255(Suppl 6):2–6.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Wingerchuk DM,
    2. Lucchinetti CF,
    3. Noseworthy JH
    (2001) Multiple sclerosis:current pathophysiological concepts. Lab Invest 81:263–281.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Ascherio A,
    2. Munger K
    (2016) Epidemiology of multiple sclerosis:from risk factors to prevention--an update. Semin Neurol 36:103–114.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Conradi S,
    2. Malzahn U,
    3. Paul F,
    4. Quill S,
    5. Harms L,
    6. Bergh FT,
    7. et al.
    (2013) Breastfeeding is associated with lower risk for multiple sclerosis. Mult Scler 19:553–558.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Mansouri B,
    2. Asadollahi S,
    3. Heidari K,
    4. Fakhri M,
    5. Assarzadegan F,
    6. Nazari M,
    7. et al.
    (2014) Risk factors for increased multiple sclerosis susceptibility in the Iranian Population. J Clin Neurosci 21:2207–2211.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Bohlega S,
    2. Inshasi J,
    3. Al Tahan AR,
    4. Madani AB,
    5. Qahtani H,
    6. Rieckmann P
    (2013) Multiple sclerosis in the Arabian Gulf countries:a consensus statement. J Neurol 260:2959–2963.
    OpenUrl
    1. Al Wutayd O,
    2. Mohamed AG,
    3. Saeedi J,
    4. Al Otaibi H,
    5. Al Jumah M
    (2018) Environmental exposures and the risk of multiple sclerosis in Saudi Arabia. BMC neurol 18:86.
    OpenUrl
  15. ↵
    1. Al-Jumah M,
    2. Bunyan R,
    3. Otaibi HA,
    4. Cupler E,
    5. Ishak S,
    6. Shami S,
    7. et al.
    (2018) The Saudi Arabian National Multiple Sclerosis Registry (NMSR):initial results Saudi MS Registry Study Group*(P2.390). Neurology 90:2–390.
    OpenUrl
  16. ↵
    General Authority of Statistics, Population Characteristics surveys 2017, Available from: https://www.stats.gov.sa/sites/default/files/msh_lkhsys_lskny_2017_.pdf.
  17. ↵
    1. Hudaif HSA,
    2. Bwardi NA,
    3. Kojan S
    (2014) Assessment of multiple sclerosis awareness and knowledge among the Saudi population in Riyadh City. Mult Scler Relat Disord 3:758.
    OpenUrl
  18. ↵
    1. Taber KS
    (2018) The use of Cronbach's alpha when developing and reporting research instruments in Science education. Res Sci Educ 48:1273–1296.
    OpenUrl
  19. ↵
    1. Aljumah M,
    2. Alroughani R,
    3. Alsharoqi I,
    4. Bohlega SA,
    5. Dahdaleh M,
    6. Deleu D,
    7. et al.
    (2013) Future of management of multiple sclerosis in the middle East:a consensus view from specialists in ten countries. Mult Scler Int 2013:952321.
    OpenUrl
  20. ↵
    1. Amer MG,
    2. AlZahrani WA,
    3. AlZahrani AA,
    4. Altalhi FA,
    5. Alrubaie SS,
    6. Alsini RA,
    7. et al.
    (2016) Assessment of multiple sclerosis awareness:knowledge and attitude among saudi population in Taif City, KSA. Int J Adv Res 4:1758–1766.
    OpenUrl
    1. Alotaibi FF
    (2016) Assessment of knowledge and attitude of women in Majmaah city, Saudi Arabia about multiple sclerosis, 2016. J Neurol Neurophysiol 7:74.
    OpenUrl
  22. ↵
    1. Derakhshandi H,
    2. Etemadifar M,
    3. Feizi A,
    4. Abtahi SH,
    5. Minagar A,
    6. Abtahi MA,
    7. et al.
    (2012) Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis:a double blind, randomized, placebo-controlled pilot clinical trial. Acta Neurol Belg 113:257–263.
    OpenUrl
  23. ↵
    1. Lolli F,
    2. Rovero P,
    3. Chelli M,
    4. Papini AM
    (2014) Toward biomarkers in multiple sclerosis:new advances. Expert Rev Neurother 6:781–794.
    OpenUrl
  24. ↵
    1. MSIF Atlas of MS 2013 [Internet]
    MS International Federation, Available from: https://www.msif.org/resource/msif-atlas-of-ms-2013/. cited 2020Jun30.
  25. ↵
    1. Miller JR
    (2004) The importance of early diagnosis of multiple sclerosis. J Manag Care Pharm 10:S4–S11.
    OpenUrlPubMed
  26. ↵
    1. Yamout BI,
    2. Dahdaleh M,
    3. Al Jumah MA,
    4. Al-Shammri S,
    5. Al Sharoqi A,
    6. Al-Tahan AR,
    7. et al.
    (2010) Adherence to disease-modifying drugs in patients with multiple sclerosis:a consensus statement from the Middle East MS Advisory Group. Int J Neurosci 120:273–279.
    OpenUrlPubMed
  27. ↵
    1. Kampman MT,
    2. Steffensen LH,
    3. Mellgren SI,
    4. Jørgensen L
    (2012) Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis:exploratory outcomes from a double-blind randomised controlled trial. Mult Scler 18:1144–1151.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Hedström AK,
    2. Bomfim IL,
    3. Barcellos L,
    4. Gianfrancesco M,
    5. Schaefer C,
    6. Kockum I,
    7. et al.
    (2014) Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology 82:865–872.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Gold R,
    2. Wolinsky JS,
    3. Amato MP,
    4. Comi G
    (2010) Evolving expectations around early management of multiple sclerosis. Ther Adv Neurol Disord 3:351–367.
    OpenUrlCrossRefPubMed
  30. ↵
    1. AlJumah M,
    2. Bunyan R,
    3. Al Otaibi H,
    4. Al Towaijri G,
    5. Karim A,
    6. Al Malik Y,
    7. et al.
    (2020) Rising prevalence of multiple sclerosis in Saudi Srabia, a descriptive study. BMC neurol 20:1–7.
    OpenUrl
  31. ↵
    1. Arhan E,
    2. Serdaroglu A,
    3. Soysal S,
    4. Ozcelik A,
    5. Gucuyener K,
    6. Demir E
    (2009) Assessment of mothers'knowledge and perceptions of electroencephalography and determination of the short-term effect of an informational leaflet. Epilepsy Behav 15:491–495.
    OpenUrlPubMed
  32. ↵
    1. Bhagavathula AS,
    2. Aldhaleei WA,
    3. Rahmani J,
    4. Mahabadi MA,
    5. Bandari DK
    (2020) Knowledge and perceptions of COVID-19 among health care workers:cross-sectional study. JMIR Public Health Surveill 6:e19160.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section